Kestra Medical Technologies (KMTS) Shares Outstanding (Diluted Average) (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Shares Outstanding (Diluted Average) data on file, last reported at $55.8 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $55.8 million, up 180.85% year-over-year; the trailing twelve-month figure through Jan 2026 was $55.8 million (up 180.85% YoY), and the FY2025 annual result was $24.6 million, up 23.63% from the prior year.
• Shares Outstanding (Diluted Average) grew to $55.8 million in Q1 2026 per KMTS's latest filing, from $51.3 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $55.8 million in Q1 2026 and troughed at $19.9 million in Q1 2024.
• A 3-year average of $31.4 million and a median of $19.9 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Diluted Average) changed 0.0% in 2025, then surged 180.85% in 2026.
• A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $19.9 million in 2024, then jumped by 158.18% to $51.3 million in 2025, then climbed by 8.78% to $55.8 million in 2026.
• Business Quant data shows KMTS's Shares Outstanding (Diluted Average) at $55.8 million in Q1 2026, $51.3 million in Q4 2025, and $51.3 million in Q3 2025.